4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001193522-25-000004
Director sold 5,950 shares at an average $512.13 ($3,047,201)
- Director acquired 5,950 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SULLIVAN LOUIS W · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 1 in the form | +3,230 | $183.98 | $594,255 | 3,230 | I |
| 2025-12-22 | Exercise or conversion : show line 2 in the form | +2,720 | $229.81 | $625,083 | 5,950 | I |
| 2025-12-22 | Sale : show line 3 in the form | −1,087 | $511.22 | $555,700 | 4,863 | I |
| 2025-12-22 | Sale : show line 4 in the form | −4,863 | $512.34 | $2,491,501 | 0 | I |
| Open-market sales · 5,950 sh · avg $512.13 · $3,047,201 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 5 in the form Stock Options | −3,230 | 0 | I |
| 2025-12-22 | Exercise or conversion : show line 6 in the form Stock Options | −2,720 | 1,840 | I |
Loading xslF345X05/primarydocument.xml…